SAGE Therapeutics (SAGE) Misses Q1 EPS by 12c
SAGE Therapeutics (NASDAQ: SAGE) reported Q1 EPS of ($3.37), $0.12 worse than the analyst estimate of ($3.25).
For earnings history and earnings-related data on SAGE Therapeutics (SAGE) click here.
SAGE Therapeutics (NASDAQ: SAGE) reported Q1 EPS of ($3.37), $0.12 worse than the analyst estimate of ($3.25).
For earnings history and earnings-related data on SAGE Therapeutics (SAGE) click here.